Osteogenesis Imperfecta clinical trials at UCSF
1 in progress, 0 open to new patients
-
A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
Sorry, not currently recruiting here
The purpose of this study is to select a suitable dose of BPS804 by measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 12 months and followed up for a further 12 months.
San Francisco, California and other locations
Last updated: